Uxin (UXIN) Common Equity (2016 - 2025)

Uxin has reported Common Equity for 10 years, with the latest figure at -$32.6 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity rose 36.46% year-over-year to -$32.6 million; the trailing twelve-month figure through Dec 2025 stood at -$32.6 million (up 36.46% YoY), and the FY2025 full-year result was -$33.0 million, up 34.51% from the prior year.
• Common Equity for Q4 2025 stood at -$32.6 million, up from -$51.2 million in the prior quarter.
• The five-year high for Common Equity was -$32.6 million in Q4 2025, with the low at -$307.9 million in Q1 2021.
• Historically, Common Equity has averaged -$142.8 million across 5 years, with a median of -$118.7 million in 2023.
• Annual changes were most pronounced in 2021 — Common Equity gained 8.35% — and 2024, when it surged 77.98%.
• Uxin's Common Equity stood at -$307.9 million in 2021, then climbed by 22.73% to -$237.9 million in 2022, then increased by 21.77% to -$186.1 million in 2023, then surged by 72.48% to -$51.2 million in 2024, then soared by 36.46% to -$32.6 million in 2025.
• The last three Common Equity figures came in at -$32.6 million (Q4 2025), -$51.2 million (Q4 2024), and -$41.0 million (Q1 2024), per Business Quant data.